Pfizer (PFE) Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. SPCX
3. ABBV
4. DFTX
5. KR
6. APGE
7. MU
8. AMBQ
9. GXO
10. NCNO

Go back to Pfizer (PFE) Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys
Pfizer Inc. (NYSE: PFE) Delayed: 25.21 --0 (-0%)
Previous Close $25.21    52 Week High $37.39 
Open $25.21    52 Week Low $28.25 
Day High $25.21    P/E 15.28 
Day Low $25.21    EPS $1.65 
Volume 104,289